Skip to content
Clinical Trials – home

Pleomorphic liposarcoma Life with Disease

2 / 2 trials open to patients5 countries

In short

Pleomorphic liposarcoma is a rare and aggressive form of cancer that develops in fat tissue, characterized by abnormally shaped immature fat cells. Understanding its progression, treatment challenges, and impact on everyday life can help patients and families navigate the difficult journey ahead with greater clarity and preparedness.

Key points

  • Pleomorphic liposarcoma is the rarest and most aggressive form of liposarcoma, with only about 46 cases diagnosed annually in England
  • More than half of patients develop metastasis, primarily to the lungs, making long-term monitoring essential
  • The five-year survival rate is approximately 59%, significantly lower than other liposarcoma subtypes
  • Most tumors present as rapidly growing masses over just three to six months, emphasizing the importance of prompt medical evaluation
  • Surgery remains the primary treatment, sometimes requiring amputation in rare cases when the tumor cannot be completely removed otherwise
  • The disease typically affects older adults with median diagnosis age of 70 years, and is more common in males than females
  • Clinical trials testing medications like eribulin and trabectedin offer hope for patients with advanced disease when standard treatments are insufficient
  • Pleomorphic liposarcoma has highly complex chromosomal alterations without consistent genetic markers, making it molecularly distinct from other liposarcoma types

Prognosis

Understanding what lies ahead when facing pleomorphic liposarcoma is essential, though it can be difficult to discuss. This particular type of cancer has the most challenging outlook among all liposarcoma subtypes. The disease tends to be highly aggressive, meaning it grows quickly and has a strong tendency to spread to other parts of the body, particularly the lungs.

Statistical information can help set realistic expectations, though each person's experience is unique. Research shows that the five-year survival rate for pleomorphic liposarcoma is approximately 59%. This means that roughly six out of ten people diagnosed with this disease are alive five years after diagnosis. It's important to remember that these are general statistics and many factors influence individual outcomes, including tumor size, location, whether it has spread, and how well it responds to treatment.

The high risk of metastasis, which means the cancer spreading to distant parts of the body, is one of the most concerning aspects of pleomorphic liposarcoma. More than 50% of cases develop metastasis, most commonly to the lungs. When cancer spreads, it becomes much more difficult to treat and can significantly affect life expectancy. This rapid spread often occurs even after the original tumor has been removed, which is why ongoing monitoring remains crucial throughout a patient's life.

Despite these sobering statistics, it's vital to maintain hope while being realistic. Medical treatments continue to advance, and some patients respond better than others to available therapies. Factors such as early detection, complete surgical removal of the tumor with clear margins, and access to specialized cancer centers can all influence outcomes in a positive direction.

Natural Progression

When pleomorphic liposarcoma develops, it typically begins as a firm mass that grows rapidly. Most patients notice the tumor growing over a relatively short period, usually between three to six months before they seek medical attention. Unlike some other cancers that grow slowly over many years, this type of cancer makes itself known fairly quickly through its aggressive growth pattern.

If left untreated, the disease follows a predictable but dangerous course. The tumor continues to enlarge, often reaching substantial size. Because it typically develops deep within soft tissues, particularly in the arms, legs, or abdomen, the growing mass can begin to press against surrounding structures. This compression can affect muscles, nerves, and blood vessels, leading to increasing problems with movement, sensation, and circulation in the affected area.

The most serious aspect of natural disease progression is the cancer's tendency to spread beyond its original location. Without treatment, cancer cells break away from the primary tumor and travel through the bloodstream to distant organs. The lungs are the most common destination for these traveling cancer cells, though other organs can be affected as well. Once the cancer has established itself in multiple locations throughout the body, the disease becomes much more difficult to control.

As the disease advances, patients typically experience worsening symptoms. What might have started as a painless lump can develop into a source of significant discomfort and functional limitation. The growing tumor mass can interfere with daily activities, and if cancer spreads to the lungs, breathing difficulties may develop. Weight loss, fatigue, and general decline in health often accompany advanced disease.

Possible Complications

Pleomorphic liposarcoma can lead to various complications, both from the disease itself and from treatments required to fight it. Understanding these potential problems helps patients and families prepare for challenges that may arise during the course of illness.

One of the most significant complications is local recurrence, meaning the cancer comes back in or near the same place where it originally developed. This happens when cancer cells that were not visible during surgery remain in the tissue and begin growing again. The risk of recurrence is notably high with pleomorphic liposarcoma, which is why doctors often recommend additional treatments like radiation therapy even after surgery.

Tumor location can create specific complications depending on where the cancer develops. When pleomorphic liposarcoma grows in an arm or leg, the expanding mass can compress nerves, causing numbness, tingling, weakness, or severe pain in the affected limb. In some cases, the tumor can interfere so severely with limb function that amputation becomes necessary to remove all cancer and prevent spread. Though rare, this represents one of the most life-altering potential complications.

Tumors developing in the abdomen or retroperitoneum (the space behind the abdominal cavity) present their own set of challenges. These tumors can grow quite large before causing noticeable symptoms because there is more space for expansion. As they grow, they may press against the stomach, intestines, or other organs, causing pain, difficulty eating, bowel obstruction, or internal bleeding.

Metastatic disease, when cancer spreads to distant organs, brings additional complications. Lung metastases, the most common form of spread, can cause shortness of breath, persistent cough, chest pain, and eventually respiratory failure if left untreated. The presence of metastatic disease dramatically changes treatment options and overall prognosis.

Treatment-related complications also deserve consideration. Surgery, especially for large tumors or those in difficult locations, can result in significant scarring, loss of tissue, nerve damage, or reduced function in the affected area. Chemotherapy and radiation therapy, while potentially beneficial, can cause side effects including fatigue, nausea, increased infection risk, and damage to healthy tissues near the tumor site.

Impact on Daily Life

Living with pleomorphic liposarcoma affects nearly every aspect of a person's daily existence. The physical presence of the tumor, combined with the emotional weight of a serious cancer diagnosis, creates challenges that extend far beyond the medical aspects of the disease.

Physical limitations often become apparent as the tumor grows or as treatment progresses. A tumor in the leg may make walking difficult or painful, affecting a person's ability to work, exercise, or perform simple tasks like climbing stairs or standing for extended periods. Arm tumors can interfere with activities requiring fine motor skills, from typing at a computer to preparing meals or dressing oneself. These functional limitations can force significant lifestyle adjustments and may require mobility aids, physical therapy, or modifications to the home environment.

The emotional toll of pleomorphic liposarcoma cannot be understated. Fear about the future, anxiety about treatment outcomes, and uncertainty about prognosis weigh heavily on patients' minds. Depression is common among people facing aggressive cancers, particularly when confronted with statistics about survival rates or the possibility that cancer may return despite treatment. These emotional challenges can affect sleep, appetite, relationships, and overall quality of life.

Work life often suffers significant disruption. Treatment schedules require frequent medical appointments, surgeries may necessitate extended recovery periods, and side effects from chemotherapy or radiation can make it difficult to maintain normal work hours or performance levels. Some patients need to reduce their hours, change jobs, or stop working entirely. This not only affects income but can also impact self-esteem and sense of purpose.

Social relationships face strain as well. Friends and family members may struggle to understand what the patient is experiencing, leading to feelings of isolation. Some people pull away, not knowing how to help or what to say. Conversely, well-meaning loved ones might become overprotective or offer unwanted advice, creating tension. Maintaining social connections while managing a serious illness requires energy that patients may not always have to spare.

Hobbies and recreational activities often fall by the wayside. Physical limitations may make former favorite activities impossible or difficult. Fatigue from treatment can leave little energy for leisure pursuits. The mental preoccupation with illness can diminish interest in activities that once brought joy. Patients may grieve these losses while simultaneously trying to cope with their diagnosis.

Despite these challenges, many patients find ways to adapt and maintain quality of life. Some helpful strategies include setting realistic expectations about what can be accomplished each day, focusing on activities that remain possible rather than those that are lost, accepting help from others, and seeking support from counselors or support groups who understand the cancer experience. Physical therapy and occupational therapy can help maximize function and independence. Finding small ways to maintain control over daily life can provide important psychological benefits during a time when so much feels uncertain.

Support for Family

When someone is diagnosed with pleomorphic liposarcoma, the entire family is affected. Family members often want to help but may not know where to start, especially when it comes to understanding treatment options and clinical trials that might offer hope.

Clinical trials represent an important option for pleomorphic liposarcoma patients. Because this is a rare and aggressive cancer, standard treatments may not always work as well as hoped. Clinical trials test new medications, treatment combinations, or approaches that might prove more effective than existing options. For families supporting someone with this diagnosis, understanding clinical trials and how to access them can be valuable.

Family members can help their loved one find appropriate clinical trials in several practical ways. Start by asking the patient's oncologist about trials that might be suitable. Doctors who specialize in sarcomas are often aware of ongoing research studies. Additionally, online registries like ClinicalTrials.gov provide searchable databases of trials throughout the world. Searching for "pleomorphic liposarcoma" and the patient's location can reveal relevant options. Many cancer centers also have clinical trial coordinators who can help identify suitable studies.

Understanding what participation in a clinical trial involves helps families support informed decision-making. Trials have specific eligibility criteria that determine who can participate. These might include factors like cancer stage, previous treatments received, age, and overall health status. Reading through trial descriptions together and making lists of questions can help both patient and family feel more prepared when discussing options with medical teams.

Preparing for trial participation involves practical support that families can provide. This might include helping organize medical records that need to be submitted, arranging transportation to trial sites that may be far from home, managing additional appointment schedules, tracking medications and side effects, and serving as a second set of ears during medical consultations when complex information is being discussed. Having someone to take notes and ask questions during appointments can be invaluable.

Emotional support remains crucial throughout the clinical trial process. Patients may feel hopeful about new treatment possibilities but also anxious about unknown risks or potential side effects. They may worry about being "experimented on" or feel guilty if they decide not to participate. Family members can provide reassurance, help weigh pros and cons, and support whatever decision the patient ultimately makes.

Family members should also remember to care for themselves during this challenging time. Supporting someone with aggressive cancer is emotionally and physically exhausting. Seeking support from other families who have been through similar experiences, either through hospital programs or online communities, can provide valuable perspective and coping strategies. Taking breaks when possible, maintaining some normal routines, and seeking professional counseling if needed are all important aspects of self-care that enable family members to continue providing support over the long term.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Eribulin – Systemic therapy that has shown promising activity in advanced pleomorphic liposarcoma cases
  • Trabectedin – Systemic therapy that has demonstrated promising activity compared to conventional treatments for advanced disease

Did you know?

  1. Pleomorphic liposarcoma accounts for less than 5% of all liposarcomas, making it the rarest subtype within an already rare group of cancers.
  2. The disease typically occurs in people in their seventies, with peak incidence in the seventh decade of life, though exceptional pediatric cases have been documented.
  3. Unlike well-differentiated liposarcoma which has amplification of MDM2 and CDK4 genes, pleomorphic liposarcoma shows highly complex chromosomal alterations with no consistent genetic markers, making molecular diagnosis challenging.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Pleomorphic liposarcoma

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ttf-Ngr
  • Sponsor:Universitaet Muenster

Leiomyosarcoma+5

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Intensity Therapeutics Inc.
See all 2 trials →filters applied: condition = Pleomorphic liposarcoma

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).